5-73056105-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_138782.3(FCHO2):c.1251T>A(p.Asn417Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000786 in 1,527,492 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138782.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO2 | NM_138782.3 | c.1251T>A | p.Asn417Lys | missense_variant, splice_region_variant | 16/26 | ENST00000430046.7 | NP_620137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO2 | ENST00000430046.7 | c.1251T>A | p.Asn417Lys | missense_variant, splice_region_variant | 16/26 | 1 | NM_138782.3 | ENSP00000393776.2 | ||
FCHO2 | ENST00000512348.5 | c.1152T>A | p.Asn384Lys | missense_variant, splice_region_variant | 15/25 | 2 | ENSP00000427296.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000145 AC: 2AN: 137774Hom.: 0 AF XY: 0.0000137 AC XY: 1AN XY: 72738
GnomAD4 exome AF: 0.00000364 AC: 5AN: 1375294Hom.: 0 Cov.: 27 AF XY: 0.00000295 AC XY: 2AN XY: 678102
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2024 | The c.1251T>A (p.N417K) alteration is located in exon 16 (coding exon 16) of the FCHO2 gene. This alteration results from a T to A substitution at nucleotide position 1251, causing the asparagine (N) at amino acid position 417 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at